“Efficacy of Daclatasvir Plus Peginterferon Alfa and Ribavirin for Patients With Chronic Hepatitis C Genotype 4 Infection”. 2017. Bangladesh Journal of Pharmacology 12 (1): 12-22. https://doi.org/10.3329/bjp.v12i1.29940.